Evaluation of the effects of the FODMAP diet and probiotics on irritable bowel syndrome (IBS) symptoms, quality of life and depression in women with IBS

Background The present study aimed to evaluate the effects of fermented oligosaccharide, disaccharide, monosaccharide and polyols (FODMAP) diet therapy and probiotics on irritable bowel syndrome (IBS) symptoms, quality of life and depression in women diagnosed with IBS. Methods For the study, 52 fem...

Full description

Saved in:
Bibliographic Details
Published inJournal of human nutrition and dietetics Vol. 37; no. 1; pp. 5 - 17
Main Authors Ustaoğlu, Tuba, Tek, Nilüfer Acar, Yıldırım, Abdullah Emre
Format Journal Article
LanguageEnglish
Published England Blackwell Publishing Ltd 01.02.2024
Subjects
Online AccessGet full text
ISSN0952-3871
1365-277X
1365-277X
DOI10.1111/jhn.13194

Cover

Abstract Background The present study aimed to evaluate the effects of fermented oligosaccharide, disaccharide, monosaccharide and polyols (FODMAP) diet therapy and probiotics on irritable bowel syndrome (IBS) symptoms, quality of life and depression in women diagnosed with IBS. Methods For the study, 52 female IBS patients between the ages of 20 and 55 were enrolled. Individuals were monitored for 6 weeks in two groups. A low‐FODMAP diet was given to the first group and a low‐FODMAP diet plus a probiotic supplement was given to the second group (Lactobacillus rhamnosus). Three‐day food intake records were kept at the start of the study and continued up to its conclusion, with a weekly check‐in in between. At the start and end of the trial, participants completed the Hospital Anxiety and Depression Scale, IBS Quality of Life Scale (IBS‐QOL) and IBS Symptom Severity Score (IBS‐SSS). The Bristol Stool Scale was also used by the subjects to record their daily stool densities. Results At the end of the study, it was determined that the daily intake of FODMAP (lactose [g] + oligosaccharides [g] + mannitol [g] + sorbitol [g]) decreased significantly in both groups (p < 0.05). At the end of the study, it was determined that the IBS‐SSS, anxiety and depression scores of the individuals in both groups decreased significantly and their IBS‐QOL scores increased significantly (p < 0.05). However, the difference between these values between the groups was not statistically significant (p > 0.05). Conclusions A low‐FODMAP diet has been demonstrated to benefit people by lessening the severity of their IBS symptoms and enhancing their quality of life. No evidence was found, however, to indicate that the FODMAP diet would be more beneficial on these metrics if additional probiotics were used. It should be emphasised that the reaction of probiotic strains may vary depending on the IBS subtype. When symptoms worsen, it may be advised to follow a low‐fermented oligosaccharide, disaccharide, monosaccharide and polyols (FODMAP) diet for 2–8 weeks before gradually reintroducing the person to their regular eating routine. To prevent long‐term nutrient deficits, it is important to monitor energy and nutrient intakes during the diet under the direction of a nutritionist. Highlights A low fermented oligosaccharide, disaccharide, monosaccharide and polyols (FODMAP) diet may be recommended to apply for 2–8 weeks when symptoms become severe, gradually transitioning the individual to the normal nutrition process when symptoms subside. It is necessary to follow up the energy and nutrient intakes according to individual characteristics during the diet under the guidance of a dietitian to prevent nutrient deficiencies in the long term. Patients should be given dietary advice on choosing high‐fibre, low‐FODMAP‐sourced fruits, vegetables and grains to balance their daily fibre intake. FODMAP restriction reduces the intake of prebiotics, which affects the gastrointestinal microbiota.
AbstractList The present study aimed to evaluate the effects of fermented oligosaccharide, disaccharide, monosaccharide and polyols (FODMAP) diet therapy and probiotics on irritable bowel syndrome (IBS) symptoms, quality of life and depression in women diagnosed with IBS.BACKGROUNDThe present study aimed to evaluate the effects of fermented oligosaccharide, disaccharide, monosaccharide and polyols (FODMAP) diet therapy and probiotics on irritable bowel syndrome (IBS) symptoms, quality of life and depression in women diagnosed with IBS.For the study, 52 female IBS patients between the ages of 20 and 55 were enrolled. Individuals were monitored for 6 weeks in two groups. A low-FODMAP diet was given to the first group and a low-FODMAP diet plus a probiotic supplement was given to the second group (Lactobacillus rhamnosus). Three-day food intake records were kept at the start of the study and continued up to its conclusion, with a weekly check-in in between. At the start and end of the trial, participants completed the Hospital Anxiety and Depression Scale, IBS Quality of Life Scale (IBS-QOL) and IBS Symptom Severity Score (IBS-SSS). The Bristol Stool Scale was also used by the subjects to record their daily stool densities.METHODSFor the study, 52 female IBS patients between the ages of 20 and 55 were enrolled. Individuals were monitored for 6 weeks in two groups. A low-FODMAP diet was given to the first group and a low-FODMAP diet plus a probiotic supplement was given to the second group (Lactobacillus rhamnosus). Three-day food intake records were kept at the start of the study and continued up to its conclusion, with a weekly check-in in between. At the start and end of the trial, participants completed the Hospital Anxiety and Depression Scale, IBS Quality of Life Scale (IBS-QOL) and IBS Symptom Severity Score (IBS-SSS). The Bristol Stool Scale was also used by the subjects to record their daily stool densities.At the end of the study, it was determined that the daily intake of FODMAP (lactose [g] + oligosaccharides [g] + mannitol [g] + sorbitol [g]) decreased significantly in both groups (p < 0.05). At the end of the study, it was determined that the IBS-SSS, anxiety and depression scores of the individuals in both groups decreased significantly and their IBS-QOL scores increased significantly (p < 0.05). However, the difference between these values between the groups was not statistically significant (p > 0.05).RESULTSAt the end of the study, it was determined that the daily intake of FODMAP (lactose [g] + oligosaccharides [g] + mannitol [g] + sorbitol [g]) decreased significantly in both groups (p < 0.05). At the end of the study, it was determined that the IBS-SSS, anxiety and depression scores of the individuals in both groups decreased significantly and their IBS-QOL scores increased significantly (p < 0.05). However, the difference between these values between the groups was not statistically significant (p > 0.05).A low-FODMAP diet has been demonstrated to benefit people by lessening the severity of their IBS symptoms and enhancing their quality of life. No evidence was found, however, to indicate that the FODMAP diet would be more beneficial on these metrics if additional probiotics were used. It should be emphasised that the reaction of probiotic strains may vary depending on the IBS subtype.CONCLUSIONSA low-FODMAP diet has been demonstrated to benefit people by lessening the severity of their IBS symptoms and enhancing their quality of life. No evidence was found, however, to indicate that the FODMAP diet would be more beneficial on these metrics if additional probiotics were used. It should be emphasised that the reaction of probiotic strains may vary depending on the IBS subtype.
The present study aimed to evaluate the effects of fermented oligosaccharide, disaccharide, monosaccharide and polyols (FODMAP) diet therapy and probiotics on irritable bowel syndrome (IBS) symptoms, quality of life and depression in women diagnosed with IBS. For the study, 52 female IBS patients between the ages of 20 and 55 were enrolled. Individuals were monitored for 6 weeks in two groups. A low-FODMAP diet was given to the first group and a low-FODMAP diet plus a probiotic supplement was given to the second group (Lactobacillus rhamnosus). Three-day food intake records were kept at the start of the study and continued up to its conclusion, with a weekly check-in in between. At the start and end of the trial, participants completed the Hospital Anxiety and Depression Scale, IBS Quality of Life Scale (IBS-QOL) and IBS Symptom Severity Score (IBS-SSS). The Bristol Stool Scale was also used by the subjects to record their daily stool densities. At the end of the study, it was determined that the daily intake of FODMAP (lactose [g] + oligosaccharides [g] + mannitol [g] + sorbitol [g]) decreased significantly in both groups (p < 0.05). At the end of the study, it was determined that the IBS-SSS, anxiety and depression scores of the individuals in both groups decreased significantly and their IBS-QOL scores increased significantly (p < 0.05). However, the difference between these values between the groups was not statistically significant (p > 0.05). A low-FODMAP diet has been demonstrated to benefit people by lessening the severity of their IBS symptoms and enhancing their quality of life. No evidence was found, however, to indicate that the FODMAP diet would be more beneficial on these metrics if additional probiotics were used. It should be emphasised that the reaction of probiotic strains may vary depending on the IBS subtype.
Background The present study aimed to evaluate the effects of fermented oligosaccharide, disaccharide, monosaccharide and polyols (FODMAP) diet therapy and probiotics on irritable bowel syndrome (IBS) symptoms, quality of life and depression in women diagnosed with IBS. Methods For the study, 52 female IBS patients between the ages of 20 and 55 were enrolled. Individuals were monitored for 6 weeks in two groups. A low‐FODMAP diet was given to the first group and a low‐FODMAP diet plus a probiotic supplement was given to the second group (Lactobacillus rhamnosus). Three‐day food intake records were kept at the start of the study and continued up to its conclusion, with a weekly check‐in in between. At the start and end of the trial, participants completed the Hospital Anxiety and Depression Scale, IBS Quality of Life Scale (IBS‐QOL) and IBS Symptom Severity Score (IBS‐SSS). The Bristol Stool Scale was also used by the subjects to record their daily stool densities. Results At the end of the study, it was determined that the daily intake of FODMAP (lactose [g] + oligosaccharides [g] + mannitol [g] + sorbitol [g]) decreased significantly in both groups (p < 0.05). At the end of the study, it was determined that the IBS‐SSS, anxiety and depression scores of the individuals in both groups decreased significantly and their IBS‐QOL scores increased significantly (p < 0.05). However, the difference between these values between the groups was not statistically significant (p > 0.05). Conclusions A low‐FODMAP diet has been demonstrated to benefit people by lessening the severity of their IBS symptoms and enhancing their quality of life. No evidence was found, however, to indicate that the FODMAP diet would be more beneficial on these metrics if additional probiotics were used. It should be emphasised that the reaction of probiotic strains may vary depending on the IBS subtype. When symptoms worsen, it may be advised to follow a low‐fermented oligosaccharide, disaccharide, monosaccharide and polyols (FODMAP) diet for 2–8 weeks before gradually reintroducing the person to their regular eating routine. To prevent long‐term nutrient deficits, it is important to monitor energy and nutrient intakes during the diet under the direction of a nutritionist. Highlights A low fermented oligosaccharide, disaccharide, monosaccharide and polyols (FODMAP) diet may be recommended to apply for 2–8 weeks when symptoms become severe, gradually transitioning the individual to the normal nutrition process when symptoms subside. It is necessary to follow up the energy and nutrient intakes according to individual characteristics during the diet under the guidance of a dietitian to prevent nutrient deficiencies in the long term. Patients should be given dietary advice on choosing high‐fibre, low‐FODMAP‐sourced fruits, vegetables and grains to balance their daily fibre intake. FODMAP restriction reduces the intake of prebiotics, which affects the gastrointestinal microbiota.
BACKGROUND: The present study aimed to evaluate the effects of fermented oligosaccharide, disaccharide, monosaccharide and polyols (FODMAP) diet therapy and probiotics on irritable bowel syndrome (IBS) symptoms, quality of life and depression in women diagnosed with IBS. METHODS: For the study, 52 female IBS patients between the ages of 20 and 55 were enrolled. Individuals were monitored for 6 weeks in two groups. A low‐FODMAP diet was given to the first group and a low‐FODMAP diet plus a probiotic supplement was given to the second group (Lactobacillus rhamnosus). Three‐day food intake records were kept at the start of the study and continued up to its conclusion, with a weekly check‐in in between. At the start and end of the trial, participants completed the Hospital Anxiety and Depression Scale, IBS Quality of Life Scale (IBS‐QOL) and IBS Symptom Severity Score (IBS‐SSS). The Bristol Stool Scale was also used by the subjects to record their daily stool densities. RESULTS: At the end of the study, it was determined that the daily intake of FODMAP (lactose [g] + oligosaccharides [g] + mannitol [g] + sorbitol [g]) decreased significantly in both groups (p < 0.05). At the end of the study, it was determined that the IBS‐SSS, anxiety and depression scores of the individuals in both groups decreased significantly and their IBS‐QOL scores increased significantly (p < 0.05). However, the difference between these values between the groups was not statistically significant (p > 0.05). CONCLUSIONS: A low‐FODMAP diet has been demonstrated to benefit people by lessening the severity of their IBS symptoms and enhancing their quality of life. No evidence was found, however, to indicate that the FODMAP diet would be more beneficial on these metrics if additional probiotics were used. It should be emphasised that the reaction of probiotic strains may vary depending on the IBS subtype.
BackgroundThe present study aimed to evaluate the effects of fermented oligosaccharide, disaccharide, monosaccharide and polyols (FODMAP) diet therapy and probiotics on irritable bowel syndrome (IBS) symptoms, quality of life and depression in women diagnosed with IBS.MethodsFor the study, 52 female IBS patients between the ages of 20 and 55 were enrolled. Individuals were monitored for 6 weeks in two groups. A low‐FODMAP diet was given to the first group and a low‐FODMAP diet plus a probiotic supplement was given to the second group (Lactobacillus rhamnosus). Three‐day food intake records were kept at the start of the study and continued up to its conclusion, with a weekly check‐in in between. At the start and end of the trial, participants completed the Hospital Anxiety and Depression Scale, IBS Quality of Life Scale (IBS‐QOL) and IBS Symptom Severity Score (IBS‐SSS). The Bristol Stool Scale was also used by the subjects to record their daily stool densities.ResultsAt the end of the study, it was determined that the daily intake of FODMAP (lactose [g] + oligosaccharides [g] + mannitol [g] + sorbitol [g]) decreased significantly in both groups (p < 0.05). At the end of the study, it was determined that the IBS‐SSS, anxiety and depression scores of the individuals in both groups decreased significantly and their IBS‐QOL scores increased significantly (p < 0.05). However, the difference between these values between the groups was not statistically significant (p > 0.05).ConclusionsA low‐FODMAP diet has been demonstrated to benefit people by lessening the severity of their IBS symptoms and enhancing their quality of life. No evidence was found, however, to indicate that the FODMAP diet would be more beneficial on these metrics if additional probiotics were used. It should be emphasised that the reaction of probiotic strains may vary depending on the IBS subtype.
A low fermented oligosaccharide, disaccharide, monosaccharide and polyols (FODMAP) diet may be recommended to apply for 2–8 weeks when symptoms become severe, gradually transitioning the individual to the normal nutrition process when symptoms subside. It is necessary to follow up the energy and nutrient intakes according to individual characteristics during the diet under the guidance of a dietitian to prevent nutrient deficiencies in the long term. Patients should be given dietary advice on choosing high‐fibre, low‐FODMAP‐sourced fruits, vegetables and grains to balance their daily fibre intake. FODMAP restriction reduces the intake of prebiotics, which affects the gastrointestinal microbiota.
Author Yıldırım, Abdullah Emre
Tek, Nilüfer Acar
Ustaoğlu, Tuba
Author_xml – sequence: 1
  givenname: Tuba
  orcidid: 0000-0003-1137-0368
  surname: Ustaoğlu
  fullname: Ustaoğlu, Tuba
  email: tuba.ustaoglu@sanko.edu.tr
  organization: SANKO University
– sequence: 2
  givenname: Nilüfer Acar
  orcidid: 0000-0002-8772-9608
  surname: Tek
  fullname: Tek, Nilüfer Acar
  organization: Gazi University
– sequence: 3
  givenname: Abdullah Emre
  orcidid: 0000-0002-4386-9297
  surname: Yıldırım
  fullname: Yıldırım, Abdullah Emre
  organization: Memorial Bahçelievler Hospital
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37430435$$D View this record in MEDLINE/PubMed
BookMark eNqFkt9qFDEUxoNU7LZ64QtIwJsWnDb_ZjJzWWtrK9UKKngXMskZNsvMZJtkXPZNfFyz3d2bopiLhAO_7wvnnO8IHYx-BIReU3JG8zlfzMczymkjnqEZ5VVZMCl_HqAZaUpW8FrSQ3QU44IQUlFCXqBDLgUngpcz9Pvql-4nnZwfse9wmgOGrgOT4r68vv_w-eIrtg4S1qPFy-Bb55MzmRixC8El3faAW7-CHsf1aIMfAJ_cvv92msthmfwQ3-GHSfcurTeuvevg0crCMkCMm7_diFdZlm-X5jhrX6Lnne4jvNq9x-jH9dX3y5vi7v7j7eXFXWF4XYlCUktrWdKyJpYaKSvaSFqDqVhNDOO2BNEI3mpKKBdWSmMqKw3nYAiBmjT8GJ1sfXNfDxPEpAYXDfS9HsFPUeU5EV5RxsR_UVaXQjAhRZXRt0_QhZ_CmBtRrKGSEU6IzNSbHTW1A1i1DG7QYa3268nA-RYwwccYoFMmT3uzrBS06xUlahMAlQOgHgOQFadPFHvTv7E795XrYf1vUH26-bJV_AG6l7zd
CitedBy_id crossref_primary_10_1007_s10620_024_08671_8
crossref_primary_10_1134_S2635167624602092
crossref_primary_10_3390_nu16203515
crossref_primary_10_3390_foods13152386
crossref_primary_10_59778_sbfdergisi_1475334
Cites_doi 10.1016/j.cgh.2017.06.044
10.1111/j.1742-1241.2004.00377.x
10.1016/j.jand.2019.01.017
10.1016/j.jada.2006.07.010
10.1023/A:1018831127942
10.1186/s42506-019-0023-8
10.1016/j.genm.2009.03.004
10.3748/wjg.v20.i10.2456
10.1017/S0029665116000021
10.1053/j.gastro.2016.02.032
10.1017/S0033291796004382
10.3748/wjg.v23.i21.3771
10.1046/j.1365-2036.1997.142318000.x
10.3390/nu11071566
10.3748/wjg.v20.i43.16215
10.1159/000051878
10.1053/j.gastro.2013.09.046
10.14309/00000434-200901001-00002
10.1177/14732300080360S101
10.1097/MCG.0b013e318247157c
10.3748/wjg.v20.i34.12144
10.1111/nmo.13154
10.1097/MOG.0000000000000158
10.3390/foods7020013
10.3748/wjg.v23.i25.4632
10.1007/s00394-021-02620-1
10.1007/s00394-019-02074-6
10.3920/BM2017.0105
10.1016/S1590-8658(00)80021-3
10.3109/00365529709011203
10.1053/j.gastro.2015.07.054
10.1016/j.cgh.2012.02.029
10.1111/j.1365-277X.2011.01162.x
10.1136/gutjnl-2014-307264
10.1016/j.amjmed.2015.01.036
ContentType Journal Article
Copyright 2023 British Dietetic Association.
2024 The British Dietetic Association Ltd.
Copyright_xml – notice: 2023 British Dietetic Association.
– notice: 2024 The British Dietetic Association Ltd.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7T7
8FD
C1K
FR3
NAPCQ
P64
7X8
7S9
L.6
DOI 10.1111/jhn.13194
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Industrial and Applied Microbiology Abstracts (Microbiology A)
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
Nursing & Allied Health Premium
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Nursing & Allied Health Premium
Engineering Research Database
Technology Research Database
Industrial and Applied Microbiology Abstracts (Microbiology A)
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE

AGRICOLA
Nursing & Allied Health Premium
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Diet & Clinical Nutrition
EISSN 1365-277X
EndPage 17
ExternalDocumentID 37430435
10_1111_jhn_13194
JHN13194
Genre article
Clinical Trial
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Responsible investigator, T.U.
GroupedDBID ---
.3N
.GA
.GJ
.Y3
05W
0R~
10A
1OB
1OC
29K
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
6PF
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHBH
AAHQN
AAIPD
AAMMB
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAWTL
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABDPE
ABEML
ABFSI
ABIVO
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCZN
ACFBH
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
AEFGJ
AEGXH
AEIGN
AEIMD
AENEX
AEUYR
AEYWJ
AFBPY
AFEBI
AFFPM
AFGKR
AFRAH
AFWVQ
AFZJQ
AGHNM
AGQPQ
AGXDD
AGYGG
AHBTC
AHEFC
AI.
AIACR
AIDQK
AIDYY
AITYG
AIURR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
D-I
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
DUUFO
E.L
EBS
EJD
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
PZZ
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
TEORI
UB1
V8K
VH1
W8V
W99
WBKPD
WH7
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQ9
WQJ
WVDHM
WXI
WXSBR
XG1
YFH
YUY
ZZTAW
~IA
~KM
~WT
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7T7
8FD
C1K
FR3
NAPCQ
P64
7X8
7S9
L.6
ID FETCH-LOGICAL-c3864-71d18751580d1c77619718ec6280c23d5e4943ba10134d77cc6d7c33ec00e8093
IEDL.DBID DR2
ISSN 0952-3871
1365-277X
IngestDate Fri Sep 05 17:20:17 EDT 2025
Fri Sep 05 08:15:38 EDT 2025
Fri Jul 25 23:28:08 EDT 2025
Mon Jul 21 05:55:24 EDT 2025
Thu Apr 24 23:09:11 EDT 2025
Sun Aug 24 04:57:33 EDT 2025
Sun Jul 06 04:45:15 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords probiotic
IBS symptom severity
depression
quality of life
irritable bowel syndrome
FODMAP diet
Language English
License 2023 British Dietetic Association.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3864-71d18751580d1c77619718ec6280c23d5e4943ba10134d77cc6d7c33ec00e8093
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
ORCID 0000-0003-1137-0368
0000-0002-8772-9608
0000-0002-4386-9297
PMID 37430435
PQID 2917203007
PQPubID 35966
PageCount 13
ParticipantIDs proquest_miscellaneous_3040361224
proquest_miscellaneous_2854424746
proquest_journals_2917203007
pubmed_primary_37430435
crossref_citationtrail_10_1111_jhn_13194
crossref_primary_10_1111_jhn_13194
wiley_primary_10_1111_jhn_13194_JHN13194
PublicationCentury 2000
PublicationDate February 2024
2024-02-00
20240201
PublicationDateYYYYMMDD 2024-02-01
PublicationDate_xml – month: 02
  year: 2024
  text: February 2024
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Oxford
PublicationTitle Journal of human nutrition and dietetics
PublicationTitleAlternate J Hum Nutr Diet
PublicationYear 2024
Publisher Blackwell Publishing Ltd
Publisher_xml – name: Blackwell Publishing Ltd
References 2015; 19
2019; 94
2015; 149
2020; 120
2019; 11
2015; 31
2017; 23
2008; 36
2003; 14
2016; 75
2006; 5
2020; 59
1997; 27
2015; 128
2007; 31
1998; 43
2012; 10
2016; 14
2001; 63
2014; 20
1997; 8
2018; 7
2004; 10
2018; 9
2016; 2
1997; 11
2017; 15
1997; 32
2015; 64
2000; 32
2016; 20
2018
2011; 24
2018; 30
2016
2009; 6
2014; 18
2005; 59
2012; 46
2021; 60
2006; 106
2009; 104
2016; 9
2010; 9
2016; 150
2014; 146
Uran B (e_1_2_11_25_1) 2016; 2
e_1_2_11_30_1
e_1_2_11_36_1
Aydemir O (e_1_2_11_26_1) 1997; 8
e_1_2_11_51_1
e_1_2_11_13_1
e_1_2_11_11_1
e_1_2_11_29_1
Watkins AM (e_1_2_11_39_1) 2016; 14
e_1_2_11_6_1
e_1_2_11_4_1
e_1_2_11_48_1
Özden A (e_1_2_11_32_1) 2006; 5
e_1_2_11_45_1
e_1_2_11_47_1
Cuomo R (e_1_2_11_14_1) 2014; 20
e_1_2_11_24_1
e_1_2_11_41_1
Pekcan AG (e_1_2_11_43_1) 2016
e_1_2_11_22_1
e_1_2_11_17_1
Nanayakkara WS (e_1_2_11_16_1) 2016; 9
e_1_2_11_38_1
e_1_2_11_19_1
Hacıhasanoğlu R (e_1_2_11_27_1) 2010; 9
e_1_2_11_50_1
e_1_2_11_10_1
e_1_2_11_31_1
e_1_2_11_35_1
e_1_2_11_12_1
e_1_2_11_33_1
e_1_2_11_7_1
Kaya M (e_1_2_11_8_1) 2016; 20
e_1_2_11_28_1
e_1_2_11_3_1
e_1_2_11_49_1
Barrett JS (e_1_2_11_15_1) 2007; 31
Mulak A (e_1_2_11_34_1) 2004; 10
Güray C (e_1_2_11_2_1) 2015; 19
Karaman N (e_1_2_11_5_1) 2003; 14
e_1_2_11_21_1
e_1_2_11_44_1
e_1_2_11_46_1
e_1_2_11_40_1
e_1_2_11_9_1
e_1_2_11_23_1
e_1_2_11_42_1
e_1_2_11_18_1
e_1_2_11_37_1
Sezer E (e_1_2_11_20_1) 2014; 18
References_xml – volume: 150
  start-page: 1262
  year: 2016
  end-page: 79
  article-title: Functional gastrointestinal disorders: history, pathophysiology, clinical features, and Rome IV
  publication-title: Gastroenterology
– volume: 20
  start-page: 398
  year: 2016
  end-page: 400
  article-title: Roma IV kriterlerine göre fonksiyonel barsak hastalıklarının yeniden değerlendirilmesi
  publication-title: GG
– volume: 128
  start-page: 817
  year: 2015
  end-page: 27
  article-title: Irritable bowel syndrome: modern concepts and management options
  publication-title: Am J Med
– volume: 30
  year: 2018
  article-title: Long‐term impact of the low‐FODMAP diet on gastrointestinal symptoms, dietary intake, patient acceptability, and healthcare utilization in irritable bowel syndrome
  publication-title: Neurogastroenterol Motil
– volume: 14
  start-page: 128
  year: 2003
  end-page: 31
  article-title: Irritable bowel syndrome prevalence in city center of Sivas
  publication-title: The Turkish J Gastroenterol
– volume: 31
  start-page: 51
  year: 2007
  article-title: Clinical ramifications of malabsorption of fructose and other short‐chain carbohydrates
  publication-title: Practical Gastroenterol
– volume: 5
  start-page: 4
  year: 2006
  end-page: 15
  article-title: Türkiye'de birinci basamak sağlık kurumlarında irritabl barsak sendromu görülme sıklığı
  publication-title: Akademik Gastroenteroloji
– volume: 59
  start-page: 2237
  year: 2020
  end-page: 48
  article-title: Low FODMAP diet significantly improves IBS symptoms: an Irish retrospective cohort study
  publication-title: Eur J Nutr
– start-page: 27
  year: 2018
  end-page: 59
– volume: 15
  start-page: 1890
  year: 2017
  end-page: 9
  article-title: A diet low in fermentable oligo‐, di‐, and monosaccharides and polyols improves quality of life and reduces activity impairment in patients with irritable bowel syndrome and diarrhea
  publication-title: Clin Gastroenterol Hepatol
– volume: 9
  start-page: 697
  year: 2018
  end-page: 706
  article-title: CL1285, LBC80R and CLR2 improve quality‐of‐life and IBS symptoms: a double‐blind, randomised, placebo‐controlled study
  publication-title: Benef Microbes
– volume: 8
  start-page: 280
  year: 1997
  end-page: 7
  article-title: Hastane Anksiyete ve Depresyon Ölçeği Türkçe Formunun Geçerlilik ve Güvenilirlik Çalışması. Reliability and Validity of the Turkish version of Hospital Anxiety and Depression Scale
  publication-title: Turk psikiyatri dergisi
– volume: 18
  start-page: 174
  year: 2014
  end-page: 9
  article-title: İrritabl bağırsak sendromunun tedavisinde prebiyotik ve probiyotik kullanımı
  publication-title: GG
– volume: 11
  start-page: 395
  year: 1997
  end-page: 402
  article-title: The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress
  publication-title: Aliment Pharmacol Ther
– volume: 20
  start-page: 8837
  year: 2014
  end-page: 45
  article-title: Irritable bowel syndrome and food interaction
  publication-title: World J Gastroenterol
– volume: 19
  start-page: 172
  year: 2015
  article-title: İrritabl Barsak Sendromunun Tanı ve Tedavisinde Yaklaşımlar
  publication-title: Güncel Gastroenteroloji
– volume: 2
  start-page: 2
  year: 2016
  article-title: Psychometric properties of the irritable bowel syndrome quality of life scale in Turkey
  publication-title: J Hepatol Gastroint Dis
– volume: 149
  start-page: 1399
  year: 2015
  end-page: 407
  article-title: Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial
  publication-title: Gastroenterology
– volume: 10
  start-page: 712
  year: 2012
  end-page: 21
  article-title: Global prevalence of and risk factors for irritable bowel syndrome: a meta‐analysis
  publication-title: Clin Gastroenterol Hepatol
– volume: 146
  start-page: 67
  year: 2014
  end-page: 75
  article-title: A diet low in FODMAPs reduces symptoms of irritable bowel syndrome
  publication-title: Gastroenterology
– volume: 9
  start-page: 209
  year: 2010
  end-page: 16
  article-title: Bir sağlık ocağına başvuran kronik hastalığı olan bireylerde anksiyete ve depresyon
  publication-title: TAF Prev Med Bull
– volume: 63
  start-page: 108
  year: 2001
  end-page: 15
  article-title: Food‐related gastrointestinal symptoms in the irritable bowel syndrome
  publication-title: Digestion
– volume: 23
  start-page: 3771
  year: 2017
  end-page: 83
  article-title: Diet in irritable bowel syndrome: what to recommend, not what to forbid to patients!
  publication-title: World J Gastroenterol
– volume: 106
  start-page: 1631
  year: 2006
  end-page: 9
  article-title: Fructose malabsorption and symptoms of irritable bowel syndrome: guidelines for effective dietary management
  publication-title: J Am Diet Assoc
– volume: 11
  start-page: 1566
  year: 2019
  article-title: Effect of three diets (low‐FODMAP, gluten‐free and balanced) on irritable bowel syndrome symptoms and health‐related quality of life
  publication-title: Nutrients
– start-page: 29
  year: 2016
  end-page: 45
– volume: 31
  start-page: 166
  year: 2015
  end-page: 71
  article-title: Diet and irritable bowel syndrome
  publication-title: Curr Opin Gastroenterol
– volume: 20
  start-page: 12144
  year: 2014
  end-page: 60
  article-title: Irritable bowel syndrome: a clinical review
  publication-title: World J Gastroenterol
– volume: 32
  start-page: 920
  year: 1997
  end-page: 4
  article-title: Stool form scale as a useful guide to intestinal transit time
  publication-title: Scand J Gastroenterol
– volume: 120
  start-page: 535
  year: 2020
  end-page: 47
  article-title: Nutrient intake, diet quality, and diet diversity in irritable bowel syndrome and the impact of the low FODMAP diet
  publication-title: J Acad Nutr Diet
– volume: 32
  start-page: 294
  year: 2000
  end-page: 301
  article-title: Bacterial supplementation in the irritable bowel syndrome. A randomised doubleblind placebo‐controlled crossover study
  publication-title: Dig Liver Dis
– volume: 59
  start-page: 361
  issue: 3
  year: 2005
  end-page: 9
  article-title: The epidemiological aspects of irritable bowel syndrome in Southeastern Anatolia: a stratified randomised community‐based study
  publication-title: Int J Clin Pract
– volume: 14
  start-page: 9
  year: 2016
  end-page: 17
  article-title: Is the restriction of Fermentable Short Chain Carbohydrate (FODMAP) a credible solution for the Irritable Bowel Syndrome patient?
  publication-title: S Afr Gastroenterol Rev
– volume: 64
  start-page: 93
  year: 2015
  end-page: 100
  article-title: Diets that differ in their FODMAP content alter the colonic luminal microenvironment
  publication-title: Gut
– volume: 43
  start-page: 400
  year: 1998
  end-page: 11
  article-title: Quality of life in persons with irritable bowel syndrome (development and validation of a new measure)
  publication-title: Dig Dis Sci
– volume: 10
  start-page: RA55
  year: 2004
  end-page: 62
  article-title: Irritable bowel syndrome: a model of the brain‐gut interactions
  publication-title: Med Sci Monit
– volume: 94
  start-page: 23
  year: 2019
  article-title: Factors associated with irritable bowel syndrome among medical students at Ain Shams University
  publication-title: J Egypt Public Health Assoc
– volume: 75
  start-page: 306
  year: 2016
  end-page: 18
  article-title: Altered gastrointestinal microbiota in irritable bowel syndrome and its modification by diet: probiotics, prebiotics and the low FODMAP diet
  publication-title: Proc Nutr Soc
– volume: 9
  start-page: 131
  year: 2016
  article-title: Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date
  publication-title: Clin Exp Gastroenterol
– volume: 24
  start-page: 487
  year: 2011
  end-page: 95
  article-title: Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome: IBS symptom response to a low FODMAP diet
  publication-title: J Hum Nutr Diet
– volume: 104
  start-page: 1
  year: 2009
  end-page: 35
  article-title: An evidence‐based position statement on the management of irritable bowel syndrome
  publication-title: Am J Gastroenterol
– volume: 20
  start-page: 8886
  year: 2014
  end-page: 97
  article-title: Intestinal microbiota in pathophysiology and management of irritable bowel syndrome
  publication-title: World J Gastroenterol
– volume: 7
  start-page: 13
  issue: 2
  year: 2018
  article-title: The role of bacteria, probiotics and diet in irritable bowel syndrome
  publication-title: Foods
– volume: 20
  start-page: 16215
  year: 2014
  end-page: 26
  article-title: Ehealth: low FODMAP diet vs GG in irritable bowel syndrome
  publication-title: World J Gastroenterol
– volume: 46
  start-page: 356
  year: 2012
  end-page: 66
  article-title: A global perspective on irritable bowel syndrome: a consensus statement of the World Gastroenterology Organisation Summit Task Force on irritable bowel syndrome
  publication-title: J Clin Gastroenterol
– volume: 6
  start-page: 152
  year: 2009
  end-page: 67
  article-title: Do fluctuations in ovarian hormones affect gastrointestinal symptoms in women with irritable bowel syndrome?
  publication-title: Gend Med
– volume: 36
  start-page: 1A
  year: 2008
  end-page: 53
  article-title: Probiotics in clinical practice: an overview
  publication-title: J Int Med Res
– volume: 23
  start-page: 4632
  year: 2017
  article-title: Long‐term irritable bowel syndrome symptom control with reintroduction of selected FODMAPs
  publication-title: World J Gastroenterol
– volume: 27
  start-page: 363
  year: 1997
  end-page: 70
  article-title: A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects
  publication-title: Psychol Med
– volume: 60
  start-page: 3523
  year: 2021
  end-page: 3
  article-title: Correction to: efficacy of a low‐FODMAP diet in adult irritable bowel syndrome: a systematic review and meta‐analysis
  publication-title: Eur J Nutr
– ident: e_1_2_11_36_1
  doi: 10.1016/j.cgh.2017.06.044
– ident: e_1_2_11_31_1
  doi: 10.1111/j.1742-1241.2004.00377.x
– ident: e_1_2_11_37_1
  doi: 10.1016/j.jand.2019.01.017
– ident: e_1_2_11_40_1
– volume: 10
  start-page: RA55
  year: 2004
  ident: e_1_2_11_34_1
  article-title: Irritable bowel syndrome: a model of the brain‐gut interactions
  publication-title: Med Sci Monit
– ident: e_1_2_11_18_1
  doi: 10.1016/j.jada.2006.07.010
– ident: e_1_2_11_24_1
  doi: 10.1023/A:1018831127942
– volume: 14
  start-page: 128
  year: 2003
  ident: e_1_2_11_5_1
  article-title: Irritable bowel syndrome prevalence in city center of Sivas
  publication-title: The Turkish J Gastroenterol
– ident: e_1_2_11_30_1
  doi: 10.1186/s42506-019-0023-8
– ident: e_1_2_11_33_1
  doi: 10.1016/j.genm.2009.03.004
– volume: 14
  start-page: 9
  year: 2016
  ident: e_1_2_11_39_1
  article-title: Is the restriction of Fermentable Short Chain Carbohydrate (FODMAP) a credible solution for the Irritable Bowel Syndrome patient?
  publication-title: S Afr Gastroenterol Rev
– ident: e_1_2_11_7_1
  doi: 10.3748/wjg.v20.i10.2456
– ident: e_1_2_11_10_1
  doi: 10.1017/S0029665116000021
– ident: e_1_2_11_9_1
  doi: 10.1053/j.gastro.2016.02.032
– ident: e_1_2_11_28_1
  doi: 10.1017/S0033291796004382
– ident: e_1_2_11_44_1
  doi: 10.3748/wjg.v23.i21.3771
– volume: 9
  start-page: 209
  year: 2010
  ident: e_1_2_11_27_1
  article-title: Bir sağlık ocağına başvuran kronik hastalığı olan bireylerde anksiyete ve depresyon
  publication-title: TAF Prev Med Bull
– ident: e_1_2_11_23_1
  doi: 10.1046/j.1365-2036.1997.142318000.x
– volume: 20
  start-page: 8837
  year: 2014
  ident: e_1_2_11_14_1
  article-title: Irritable bowel syndrome and food interaction
  publication-title: World J Gastroenterol
– ident: e_1_2_11_51_1
  doi: 10.3390/nu11071566
– ident: e_1_2_11_48_1
  doi: 10.3748/wjg.v20.i43.16215
– ident: e_1_2_11_13_1
  doi: 10.1159/000051878
– start-page: 29
  volume-title: Türkiye Beslenme Rehberi 2015 (TÜBER)
  year: 2016
  ident: e_1_2_11_43_1
– ident: e_1_2_11_38_1
  doi: 10.1053/j.gastro.2013.09.046
– ident: e_1_2_11_6_1
  doi: 10.14309/00000434-200901001-00002
– ident: e_1_2_11_21_1
  doi: 10.1177/14732300080360S101
– volume: 8
  start-page: 280
  year: 1997
  ident: e_1_2_11_26_1
  article-title: Hastane Anksiyete ve Depresyon Ölçeği Türkçe Formunun Geçerlilik ve Güvenilirlik Çalışması. Reliability and Validity of the Turkish version of Hospital Anxiety and Depression Scale
  publication-title: Turk psikiyatri dergisi
– ident: e_1_2_11_3_1
  doi: 10.1097/MCG.0b013e318247157c
– volume: 2
  start-page: 2
  year: 2016
  ident: e_1_2_11_25_1
  article-title: Psychometric properties of the irritable bowel syndrome quality of life scale in Turkey
  publication-title: J Hepatol Gastroint Dis
– ident: e_1_2_11_12_1
  doi: 10.3748/wjg.v20.i34.12144
– ident: e_1_2_11_41_1
  doi: 10.1111/nmo.13154
– ident: e_1_2_11_17_1
  doi: 10.1097/MOG.0000000000000158
– ident: e_1_2_11_22_1
  doi: 10.3390/foods7020013
– ident: e_1_2_11_42_1
  doi: 10.3748/wjg.v23.i25.4632
– ident: e_1_2_11_47_1
  doi: 10.1007/s00394-021-02620-1
– ident: e_1_2_11_46_1
  doi: 10.1007/s00394-019-02074-6
– volume: 5
  start-page: 4
  year: 2006
  ident: e_1_2_11_32_1
  article-title: Türkiye'de birinci basamak sağlık kurumlarında irritabl barsak sendromu görülme sıklığı
  publication-title: Akademik Gastroenteroloji
– ident: e_1_2_11_49_1
  doi: 10.3920/BM2017.0105
– ident: e_1_2_11_50_1
  doi: 10.1016/S1590-8658(00)80021-3
– ident: e_1_2_11_29_1
  doi: 10.3109/00365529709011203
– volume: 9
  start-page: 131
  year: 2016
  ident: e_1_2_11_16_1
  article-title: Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date
  publication-title: Clin Exp Gastroenterol
– volume: 20
  start-page: 398
  year: 2016
  ident: e_1_2_11_8_1
  article-title: Roma IV kriterlerine göre fonksiyonel barsak hastalıklarının yeniden değerlendirilmesi
  publication-title: GG
– ident: e_1_2_11_35_1
  doi: 10.1053/j.gastro.2015.07.054
– ident: e_1_2_11_4_1
  doi: 10.1016/j.cgh.2012.02.029
– ident: e_1_2_11_19_1
  doi: 10.1111/j.1365-277X.2011.01162.x
– volume: 18
  start-page: 174
  year: 2014
  ident: e_1_2_11_20_1
  article-title: İrritabl bağırsak sendromunun tedavisinde prebiyotik ve probiyotik kullanımı
  publication-title: GG
– ident: e_1_2_11_45_1
  doi: 10.1136/gutjnl-2014-307264
– volume: 19
  start-page: 172
  year: 2015
  ident: e_1_2_11_2_1
  article-title: İrritabl Barsak Sendromunun Tanı ve Tedavisinde Yaklaşımlar
  publication-title: Güncel Gastroenteroloji
– volume: 31
  start-page: 51
  year: 2007
  ident: e_1_2_11_15_1
  article-title: Clinical ramifications of malabsorption of fructose and other short‐chain carbohydrates
  publication-title: Practical Gastroenterol
– ident: e_1_2_11_11_1
  doi: 10.1016/j.amjmed.2015.01.036
SSID ssj0006100
Score 2.3928711
Snippet Background The present study aimed to evaluate the effects of fermented oligosaccharide, disaccharide, monosaccharide and polyols (FODMAP) diet therapy and...
A low fermented oligosaccharide, disaccharide, monosaccharide and polyols (FODMAP) diet may be recommended to apply for 2–8 weeks when symptoms become severe,...
The present study aimed to evaluate the effects of fermented oligosaccharide, disaccharide, monosaccharide and polyols (FODMAP) diet therapy and probiotics on...
BackgroundThe present study aimed to evaluate the effects of fermented oligosaccharide, disaccharide, monosaccharide and polyols (FODMAP) diet therapy and...
BACKGROUND: The present study aimed to evaluate the effects of fermented oligosaccharide, disaccharide, monosaccharide and polyols (FODMAP) diet therapy and...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 5
SubjectTerms Adult
Anxiety
depression
Depression - etiology
Diet
diet therapy
Dietary supplements
dietetics
Disaccharides
Female
females
Fermentation
FODMAP Diet
Food intake
hospitals
Humans
IBS symptom severity
Intestine
Irritable Bowel Syndrome
Lactobacillus rhamnosus
Lactose
Mannitol
Mental depression
Mental health
Microbiota
Middle Aged
Monosaccharides
Nutrient deficiency
Nutrients
Nutrition research
Nutrition therapy
Nutritional status
Oligosaccharides
people
Polyols
Prebiotics
probiotic
Probiotics
Quality of Life
Sorbitol
Statistical analysis
Treatment Outcome
Womens health
Young Adult
Title Evaluation of the effects of the FODMAP diet and probiotics on irritable bowel syndrome (IBS) symptoms, quality of life and depression in women with IBS
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjhn.13194
https://www.ncbi.nlm.nih.gov/pubmed/37430435
https://www.proquest.com/docview/2917203007
https://www.proquest.com/docview/2854424746
https://www.proquest.com/docview/3040361224
Volume 37
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ZaxRBEC5CnvKiJvEYc1CKSAR3menuORafVjfLGnAVNZAHYZg-hixOepfsLhJ_iT831T2HRg2Ib3NUNzVMVfVX1TXfADxjJioozKU9xeOyJ4pS97KYHE9zThZTsgGTvst3mkxOxclZfLYBr9pvYWp-iK7g5jzDx2vn4IVc_urk57YfkQE5LtCIJ443f_TxJ3UUwYKw5tljjj82aliFfBdPO_LmWvQHwLyJV_2CM74LX1pV6z6Tr_31SvbV999YHP_zWe7BnQaI4rC2nG3YMHYHdoeWkvCLK3yOvjXU19x3IBjNzIquNSSiFU5bDv9d-HHc8YXjvETCk9j0iLSn4_ejd8MPqN0chdW48NRPjh4aaczs0pUnZGVQzr-ZClsKBTx6-_rTCzq9WJBGy5dYf_555WatZqXxU3V9vDSPRc8mga6yjDT2PpyOjz-_mfSa3z2QnWSJ6wrVEWVPUZyFOlKpq6_QwmlUwrJQMa5jIwaCy4KCCBc6TZVKdKo4NyoMTRYO-APYtHNrHgFGktImkWqlYi1UqgkTMVUaqUVYFITpAjhqX3yuGi5090uOKu9yonOb-zcSwNNOdFETgPxNaL-1nryJAcucUSbMKIaGaQBPutvkvW5LprBmviaZLBaCNBXJ7TKc4ixP3A5oAA9ry-w04QQAQ0K89EDevm5XMT-ZTP3B438X3YMtRhiublLfh83V5docEAZbyUPvbNcFUSrs
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dT9RAEJ8gPugLKihUEUdjDCbeZbu7_bjEl8PjciCcRiHhxTTt7jZcKL0L3MXgX-Kf6-z2Q1FJjG_9mN1M05nZ38xOfwV4yY2fUpiLOkoEeUemue7EATmeFoIsJuc9nrku33E4Opb7J8HJErxtvoWp-CHagpv1DBevrYPbgvSvXn5adn2yIHkLbksCGjb1Gnz6SR5FwIBVTHvcMsj6Na-Q6-Nphl5fjf6AmNcRq1tyhvfgS6Ns1Wly1l3Ms6769huP4_8-zX1YqbEo9ivjeQBLplyFtX5Jefj5Fb5C1x3qyu6r4A0mZk7Xah7RAscNjf8afN9tKcNxmiNBSqzbRJrT4YfBYf8jajtHWmqcOfYnyxCNNGZyYSsUWWEwm341BTYsCri9t_P5NZ2ez0ijyzdYfQF6ZWctJrlxU7WtvDRPiY5QAm1xGWnsQzge7h69G3XqPz6QqcShbQzVPiVQfhAz7avIllho7TQq5DFTXOjAyJ4UWUpxREgdRUqFOlJCGMWYiVlPPILlclqaDUA_o8xJRlqpQEsVaYJFXOUm05KlKcE6D7abN5-omg7d_pWjSNq06LRM3Bvx4EUrOqs4QP4mtNmYT1KHgcuEUzLMKYyyyIPn7W1yYLsrk5ZmuiCZOJCSNJXhzTKCQq0I7SaoB-uVabaaCMKAjEAvPZAzsJtVTPZHY3fw-N9Fn8Gd0dHhQXKwN37_BO5ygnRVz_omLM8vFuYpQbJ5tuU87weqSi8L
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3raxQxEB9qBfGLj9bHatVRRCp4RzbJPg4_nV6Pa9WzqIV-EJbdJEsPt7mjvUPqX-Kf6yT70KoF8ds-JmGWnZn8ZjL7W4Cn3IQ5hbmkp0RU9mRe6l4akeNpIchiSj7ghe_yncaTA7l3GB2uwcv2W5iaH6IruDnP8PHaOfhCl786-ZHth2RA8hJcljEhCYeIPvzkjiJcwGqiPe4IZMOGVsi38bRDzy9GfyDM84DVrzjj6_C51bVuNPnSXy2Lvvr2G43jfz7MDbjWIFEc1qZzE9aM3YDNoaUs_PgMn6HvDfVF9w0IRjOzpGsNi2iF05bEfxO-73SE4TgvkQAlNk0i7en4_ejdcB-1myO3Ghee-8nxQyONmZ24-kRRGSzmX02FLYcCbu---vicTo8XpNHpC6y__zxzs1az0vipukZemseip5NAV1pGGnsLDsY7n15Pes3_HshQ0ti1heqQ0qcwSpkOVeIKLLRyGhXzlCkudGTkQIoipygipE4SpWKdKCGMYsykbCBuw7qdW3MXMCwob5KJVirSUiWaQBFXpSm0ZHlOoC6A7fbFZ6ohQ3f_5KiyLik6spl_IwE86UQXNQPI34S2WuvJmiBwmnFKhTkFUZYE8Li7Te7r9mRya-YrkkkjKUlTGV8sIyjQithtgQZwp7bMThNBCJAR5KUH8vZ1sYrZ3mTqD-79u-gjuLI_Gmdvd6dv7sNVTniubljfgvXlyco8IDy2LB56v_sB9Vctug
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evaluation+of+the+effects+of+the+FODMAP+diet+and+probiotics+on+irritable+bowel+syndrome+%28IBS%29+symptoms%2C+quality+of+life+and+depression+in+women+with+IBS&rft.jtitle=Journal+of+human+nutrition+and+dietetics&rft.au=Ustao%C4%9Flu%2C+Tuba&rft.au=Tek%2C+Nil%C3%BCfer+Acar&rft.au=Y%C4%B1ld%C4%B1r%C4%B1m%2C+Abdullah+Emre&rft.date=2024-02-01&rft.issn=0952-3871&rft.eissn=1365-277X&rft.volume=37&rft.issue=1&rft.spage=5&rft.epage=17&rft_id=info:doi/10.1111%2Fjhn.13194&rft.externalDBID=10.1111%252Fjhn.13194&rft.externalDocID=JHN13194
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0952-3871&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0952-3871&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0952-3871&client=summon